chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initially said it was Bells Palsy, then changed to Ramsey Hunt Syndrome.  Right side Facial paralysis, Inflammation of 5, 7, and 10th nerve, matallic taste in mouth.  Most of these have resolved to slight signs.  I still have hearing and vision loss, eyes and ears are sensitive to loud noise and bright lights, Trigeminal and occipital neuralgia, balance and coordination off, tingling, twitching, numbness and nerve pain and loss of feeling in right arm, shoulder feels like it is rotting the cells and tissue and joints, constant feeling like my head could explode, nausea, vertigo, dizzy, can barely hold my head upright, muscle spasms, acid reflux, high blood pressure, E.D., Depressed and constantly in 6-10 levels of pain now for almost 8 months.  Wind 9/29/08-records received-presented to clinic on 1/1/08- with C/O headache and pressure, facial drooping and numbness, decrease in hearing, blurry vision and slight weakness to right arm times 3 days. Exhibited slurred speech, unable to blink right eye. DX: Bell's Palsy.
Pt was given Rotateq vaccination on 9-6-07 and developed virus on 9-12-07. Mom c/o of diarrhea
Child became pale and dizzy. He rested with his feet up, had BP taken twice and had oral fluids. After 20 minutes he was feeling better; he left office after 35 minutes.
Myalgia, malaise, lymphadenopathy Narrative: missed one day of work following second dose due to flu like symptoms
BELLS PALSY IN MY LEFT CHEEK AFTER ONE J&J JAB WITH PAIN AROUND LEF JAW AND EAR; LUNGS FEEL LIKE THEY HAVE FLUID IN THEM; JOINTS ACHING; EXTREME FATIGUE; PAIN IN TRAPEZIUS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (series 1) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose was not reported, 01 total, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced bells palsy in my left cheek after one j&j jab with pain around lef jaw and ear, lungs feel like they have fluid in them, joints aching, extreme fatigue and pain in trapezius. Patient did not get booster. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bells palsy in my left cheek after one j&j jab with pain around lef jaw and ear, lungs feel like they have fluid in them, joints aching, extreme fatigue and pain in trapezius was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211218021.; Sender's Comments: 20211217672-covid-19 vaccine ad26.cov2.s -Bells palsy in my left cheek after one j&j jab with pain around lef jaw and ear. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
this is one of 5 pt who recv vax & devel a nodule @ the inj site 24 to 48hr later;the inj site nodule was 4 to 6mm in diameter, red, warm, & tender;
10yr old and 15yr old siblings received vaccine in evening; next day had fever 100 - 102 lasting for 3 days, injection site swelling and nausea.
Two blood clots in right leg below the knee, calf pain, swelling of lower leg and foot, painful to walk
Itchy, swelling, warm to the touch, red, left little finger numb, Recommended Tylenol, Benadryl and icing the area, and if the arm gets worse to go see her PCP.
Patient came in next day with dad due to rash around mouth. States started 30 mins after vaccination. Redness all around mouth and then bullae formed later in evening. Otherwise fussy but well. Progressed and called on call 24 hrs later with worsening rash.
2nd dose outside of the window of Moderna vaccine schedule; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose outside of the window of Moderna vaccine schedule) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose outside of the window of Moderna vaccine schedule). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose outside of the window of Moderna vaccine schedule) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Fever - 3 to 4 days - joints ached, arm swollen, given on 2/20/17 hurt for 1 week sore, felt like had the flu, skin sore.
pt recv vax 7MAR96 & pt into clinic 13MAR w/3cm erythema w/pustule centrally located rt mid lateral thigh w/local abscess;pt placed on ATB biaxin
This spontaneous report was received from an office manager, concerning a patient of an unknown age and gender who was also a medical assistant. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 27-APR-2017, the medical assistant was topically exposed to VARIVAX reconstituted with sterile diluent (manufacturer unknown) (lot # and expiration date were not reported for neither of them), during the vaccine preparation (Occupational exposure to product). The vaccine came into contact with the medical assistant's eye, mouth and skin. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
a little sore on the injection site; This is a spontaneous report from a Pfizer Sponsored Program COVAX US Support, received from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had a little sore on the injection site. It was also reported that had her 1st dose today 26Feb2021, but they mistakenly put the wrong date which is on 24Feb2021. It's also showing on the vaccination card that her 2nd dose schedule is 18Mar2021 which is less than 21 days. The outcome of the evet was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
patients were given shots during excursions; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients were given shots during excursions) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 11-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients were given shots during excursions). On 11-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (patients were given shots during excursions) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was provided. Patient had taken first and second shot of vaccine.
She felt muscle pain from upper-left arm to left chest like an electric current is running. She took a painkiller. One week has passed since the vaccination, and the pain has gradually subsided, but it still remains.
Pain in upper left arm, checked to see large red welt (3" diameter) around injection site.  More pain when trying to lift arm.
Admit with COVID pna w/ underlying COPD. Steroids, lovenox, O2, remdesivir, azithro/rocephin. Intolerance to remdesivir and it was d/c. Improved and discharged home.
24 hours after vaccination: Flu-like symptoms with headache, chills, body aches, and fever of 102 degrees Fahrenheit.  48 hours after vaccination: Flu-like symptoms resolved, but a red lesion that is itchy and painful to the touch developed below the injection site on the left arm.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown ages and genders. The patients' medical history and concurrent conditions were not reported. On unknown dates (reported as since 18-NOV-2016), the patients might have been administered with PNEUMOVAX 23 (lot # M036161, expiry date: 06-MAY-2018). The vaccine was stored at a temperature of 9C for 176 hours (a maximum temperature reading of 9C in the morning for 11 days, from 18-NOV-2016 to 28-NOV-2016 evaluated for 16 hours each day). There was no previous temperature excursion. Data logger was not involved. No adverse effects have been reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA001425: US-009507513-1612USA001916: US-009507513-1612USA001924.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 55-year-old female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 55, in left arm, on Sep 14, 2021, at 09:00, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot#, expiry date: unknown), at the age of 55, in left arm, on Aug 20, 2021, for COVID-19 immunization. The patient's heart rate increased (fast heartbeat), onset Sep 14, 2021, at 11:00, with outcome of recovering. Additional information: It was reported 2 hours after, she said her heart began beating fast. She wanted to know if this is something she should be concerned about. It felt like it's slowing down now/getting better. But when lying down and trying to go to sleep, she could feel it. Events did not require emergency room/physician office. Prior vaccinations (within 4 weeks)/if applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine: none. Follow-up attempts completed. No further information expected.
This case was reported by a lawyer and described the occurrence of joint pain in an adult male subject who was vaccinated with Lyme disease vaccine recombinant (Lymerix) for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix. On an unspecified date after vaccination with Lymerix, the subject experienced pain and swelling in his joints. fatigue, thyroid problems, high blood pressure, hyperlipidemia, diabetes, gastrointestinal problems, dizziness memory loss, sleep disturbance, sinus problems, rashes, headache, ear ringing, cognitive problems, neuropathy, tingling, numbness, neurological injuries, autoimmune disease, and decreased activities of life. In addition, the subject suffers from rheumatologic, neurologic, and or cognitive impairment of an autoimmune, immune mediated, or other mechanism, all reported to be caused by vaccination with Lymerix. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the outcome of the events was unspecified. This information was received via a statement of injuries.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (received vaccine on Mar 7, 2022 past the BUD date of Nov 1, 2021) and product storage error (stored Moderna vaccine in refrigerator; administered vaccine on Mar 7, 2022; past the BUD date of Nov 1, 2021) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 011F21A) for COVID-19 immunization. No medical history reported. On Mar 7, 2022, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 7, 2022, patient administered expired product (received vaccine on Mar 7, 2022 past the BUD date of Nov 1, 2021). On an unknown date, patient experienced product storage error (stored Moderna vaccine in refrigerator; administered vaccine on Mar 7, 2022; past the BUD date of Nov 1, 2021). At the time of the report, administered expired product (received vaccine on Mar 7, 2022 past the BUD date of Nov 1, 2021) and product storage error (stored Moderna vaccine in refrigerator; administered vaccine on Mar 7, 2022; past the BUD date of Nov 1, 2021) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information.
BLACKED OUT/FAINTED AGAIN; BODY ACHE; CHILLS; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcoholic, and non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: Unknown) dose was not reported, administered on 22-MAR-2021 11:00 on right arm for prophylactic vaccination. No concomitant medications were reported. On 22-MAR-2021, patient experienced chills, body ache, nausea, Fever, Headache. On 23-Mar-2021, Tuesday patient woke up in am - had few glasses of water, went back to bed, at 10 am had cup of tea and around 2 pm setting in chair and blacked out. Patient did not fall, daughter tried to wake up however after no response daughter called ambulance, when EMT (Emergency Medical Technicians) came patient woke up and told EMT that she did not want to go to hospital however patient fainted again in front of EMT and they took her to ER (emergency room), checked vitals, boold work, urine test , CAT Scan, moitored heart, IV saline administered twise. All reports came to negative so ER concluded it as reaction to COVID vaccine. Patient was in ER for total 6 hours. On 24-Mar-2021, patient felt much better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, body ache, nausea, fever, headache and blacked out/fainted again was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210349895-COVID-19 VACCINE AD26.COV2.S -Blacked Out/Fainted Again. This event is considered Unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
9/23/10 - Received call - pt received H1N1 shot 11/21/09. 5 days later developed severe pain in all joints. Patient concern is whether of not she should receive the vaccine this year. Five days after vaccination patient developed severe joint pain all over her body. She lost the sense of smell and taste and developed severe kidney pain with a UTI. She states the symptoms lasted for months and the pain would come and go every 10 days. States she has seen several doctors, including infectious disease doctors, and they are unable to find anything. She is a kidney transplant recipient. Left kidney pain has abated after months and blood work is normal. Has been on numerous antibiotics. She also had diabetes and hypertension.
struggling to keep his blood sugar in check/blood sugars have been continually high; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number FC3184), via an unspecified route of administration, administered in arm left on 07Sep2021 08:30 as dose 1, single for covid-19 immunisation. Medical history included type 1 diabetes. Concomitant medication included insulin taken for type 1 diabetes, start and stop date were not reported. The patient did not receive other vaccines in four weeks. It was unknown if the patient had covid-19 prior to the vaccination. The patient informed that he was a type 1 diabetic and; he has been struggling to keep his blood sugar in check on 07Sep2021 since receiving the vaccine. His blood sugars have been continually high for no apparent reason since 07Sep2021, and his insulin dosage has increased immensely to compensate the high glucose levels (also reported as no treatment received). The patient had not recovered from the adverse event at the time of the report. The patient had not been tested for covid-19 post vaccination.   Follow-up (17Sep2021): Follow-up attempts are completed. No further information is expected.
sick; Initial information was received on 12-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves a patient (unknown demography) who was sick for 2 to 3 days (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatments, concomitant medications, vaccinations and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick for 2 to 3 days (illness, non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the lot number for this case.
Got sore arm and pounding headache in one hour. Up at midnight vomiting feverish with total body aches. My legs have never hurt so bad also felt slightly SOB. 10/3 was able to start very light food. Tried to work 10/4 but left early as still getting flash fevers. Returned to work 10 / 8 but still only feeling about 80 percent recovered.
No adverse event; 2nd dose given more than 36 days after the 1st dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given more than 36 days after the 1st dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M21A, 028K21A and 012M20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes, Hypertension, Congestive heart failure, COPD and Bronchitis.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jul-2021,  after starting , the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given more than 36 days after the 1st dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given more than 36 days after the 1st dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose given more than 36 days after the 1st dose).    No concomitant medications were reported. No treatment medications were reported.
Information has been received from a registered nurse concerning a female who on 07/06/2000 was vaccinated with a dose of varicella virus vaccine live. On 02/14/2002, the pt developed chicken pox. It was noted that unspecified medical attention was sought; however, on 02/14/2002, the nurse reported that she had not seen the pt yet. Additional info has been requested.
2 weeks after receiving my first shot I started receiving aching chest pain in the upper left portion of my chest near my heart. The aching is not consistent but appears about once a day and may last for several hours at a time. I also started receiving an aching muscular pain in my left rib cage. No bruising or other physical marking. Everything is internal.
TOOK THREE DOSES OF VIVOTIF EVERY DAY; This spontaneous case (PVX2019-1091) was received from a pharmacist on 02-May-2019. It describes a female consumer who "took three doses of Vivotif every day". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first three doses of Vivotif every day instead of every other day. She believed that the third dose was taken on 01-May-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "took three doses of Vivotif every day" was unknown.  Company's Comment: The causality of the event "took three doses of Vivotif every day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took three doses of Vivotif every day" was considered as not applicable.
diarrhea; heartburn; stool is liquid, had mucus and is yellow; fatigue; headache; nausea; pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DYSPEPSIA (heartburn), DIARRHOEA (stool is liquid, had mucus and is yellow), PAIN (pain) and FATIGUE (fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN (pain). On 02-Feb-2021, the patient experienced DIARRHOEA (diarrhea), DYSPEPSIA (heartburn), DIARRHOEA (stool is liquid, had mucus and is yellow), FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), DYSPEPSIA (heartburn), DIARRHOEA (stool is liquid, had mucus and is yellow), PAIN (pain), FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Severe tiredness and chills fever as high as 103.sore arm and body aches . Into third day and have lite chills and 101 temperature.
Severe pain in arm, 3 hard red swollen knots, swelling in arm, fever of 102.5, low blood pressure, loss of appetite, weakness, fatigue.